Genetic testing to predict sudden cardiac death: Current perspectives and future goals

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

It is known that monogenic traits may predispose young and otherwise healthy individuals to die suddenly. Diseases such as Long QT Syndrome, Brugada Syndrome and Arrhythmogenic Right Ventricular Cardiomyopathy are well known causes of arrhythmic death in young individuals. For several years the concept of "genetic predisposition" to sudden cardiac death has been limited to these uncommon diseases. In the last few years clinical data have supported the view that risk of dying suddenly may cluster in families, supporting the hypothesis of a genetic component for sudden cardiac death. In this review I will try to provide an overview of current knowledge about genetics of sudden death. I will approach this topic by discussing first where we stand in the use of genetics for risk stratification and therapy selection in monogenic diseases and I will then move to discuss the contribution of genetics to patient profiling in acquired cardiovascular diseases.

Original languageEnglish
JournalIndian Heart Journal
Volume66
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 2014

Fingerprint

Sudden Cardiac Death
Genetic Testing
Arrhythmogenic Right Ventricular Dysplasia
Brugada Syndrome
Long QT Syndrome
Genetic Predisposition to Disease
Sudden Death
Cause of Death
Cardiovascular Diseases
Therapeutics

Keywords

  • Arrhythmias
  • Genetics
  • QT interval
  • Sudden death

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Genetic testing to predict sudden cardiac death : Current perspectives and future goals. / Priori, Silvia G.

In: Indian Heart Journal, Vol. 66, No. SUPPL. 1, 2014.

Research output: Contribution to journalArticle

@article{6f6423e2f2e1404a9e954987d9ec2359,
title = "Genetic testing to predict sudden cardiac death: Current perspectives and future goals",
abstract = "It is known that monogenic traits may predispose young and otherwise healthy individuals to die suddenly. Diseases such as Long QT Syndrome, Brugada Syndrome and Arrhythmogenic Right Ventricular Cardiomyopathy are well known causes of arrhythmic death in young individuals. For several years the concept of {"}genetic predisposition{"} to sudden cardiac death has been limited to these uncommon diseases. In the last few years clinical data have supported the view that risk of dying suddenly may cluster in families, supporting the hypothesis of a genetic component for sudden cardiac death. In this review I will try to provide an overview of current knowledge about genetics of sudden death. I will approach this topic by discussing first where we stand in the use of genetics for risk stratification and therapy selection in monogenic diseases and I will then move to discuss the contribution of genetics to patient profiling in acquired cardiovascular diseases.",
keywords = "Arrhythmias, Genetics, QT interval, Sudden death",
author = "Priori, {Silvia G.}",
year = "2014",
doi = "10.1016/j.ihj.2013.11.004",
language = "English",
volume = "66",
journal = "Indian Heart Journal",
issn = "0019-4832",
publisher = "Cardiology Society of India",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Genetic testing to predict sudden cardiac death

T2 - Current perspectives and future goals

AU - Priori, Silvia G.

PY - 2014

Y1 - 2014

N2 - It is known that monogenic traits may predispose young and otherwise healthy individuals to die suddenly. Diseases such as Long QT Syndrome, Brugada Syndrome and Arrhythmogenic Right Ventricular Cardiomyopathy are well known causes of arrhythmic death in young individuals. For several years the concept of "genetic predisposition" to sudden cardiac death has been limited to these uncommon diseases. In the last few years clinical data have supported the view that risk of dying suddenly may cluster in families, supporting the hypothesis of a genetic component for sudden cardiac death. In this review I will try to provide an overview of current knowledge about genetics of sudden death. I will approach this topic by discussing first where we stand in the use of genetics for risk stratification and therapy selection in monogenic diseases and I will then move to discuss the contribution of genetics to patient profiling in acquired cardiovascular diseases.

AB - It is known that monogenic traits may predispose young and otherwise healthy individuals to die suddenly. Diseases such as Long QT Syndrome, Brugada Syndrome and Arrhythmogenic Right Ventricular Cardiomyopathy are well known causes of arrhythmic death in young individuals. For several years the concept of "genetic predisposition" to sudden cardiac death has been limited to these uncommon diseases. In the last few years clinical data have supported the view that risk of dying suddenly may cluster in families, supporting the hypothesis of a genetic component for sudden cardiac death. In this review I will try to provide an overview of current knowledge about genetics of sudden death. I will approach this topic by discussing first where we stand in the use of genetics for risk stratification and therapy selection in monogenic diseases and I will then move to discuss the contribution of genetics to patient profiling in acquired cardiovascular diseases.

KW - Arrhythmias

KW - Genetics

KW - QT interval

KW - Sudden death

UR - http://www.scopus.com/inward/record.url?scp=84896734830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896734830&partnerID=8YFLogxK

U2 - 10.1016/j.ihj.2013.11.004

DO - 10.1016/j.ihj.2013.11.004

M3 - Article

AN - SCOPUS:84896734830

VL - 66

JO - Indian Heart Journal

JF - Indian Heart Journal

SN - 0019-4832

IS - SUPPL. 1

ER -